Simplex Trading’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Sell
1,700
-1,700
-50% -$126K ﹤0.01% 4929
2025
Q4
$269K Buy
3,400
+3,300
+3,300% +$225K ﹤0.01% 3928
2025
Q3
$3K Buy
+100
New +$2.46K ﹤0.01% 8509
2025
Q1
Sell
-3,300
Closed -$29K 9014
2024
Q4
$29K Sell
3,300
-25,900
-89% -$394K ﹤0.01% 6390
2024
Q3
$457K Buy
+29,200
New +$410K ﹤0.01% 3689

Other funds holding INBX

Simplex Trading's INBX Position: Q1 2026 in Review

Simplex Trading sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 1,145 shares — an estimated $84.9K sold.

Simplex Trading first reported a position in INBX in Q3 2024 and held it in 3 quarters. The position peaked at $90.5K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Simplex Trading reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,145 Inhibrx shares in Q1 2026, an estimated $84.9K.
  • Simplex Trading first reported a position in Inhibrx in Q3 2024 and held it in 3 quarters.
  • Simplex Trading's Inhibrx position peaked at $90.5K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.